| ||||||||||||||
|
|
|||||||||||||

*Department of Anaesthesia and Intensive Care Medicine, Leopold-Franzens University, Innsbruck, Austria; and
James Cook University, Cairns Base Hospital, Australia
Address correspondence and reprint requests to Professor J. Brimacombe, Department of Anesthesia and Intensive Care, Cairns Base Hospital, The Esplanade, Cairns 4870, Australia. Address e-mail to jbrimaco@bigpond.net.au.
| Abstract |
|---|
|
|
|---|
esophageal pressure, pressure time product, respiratory drive, inspiratory time fraction, respiratory rate, noninvasive mean arterial blood pressure, and heart rate. In Group 1, measurements for CPAP were similar before and after PSV. In Group 2, measurements for PSV were similar before and after CPAP. When compared with CPAP, PSV had lower ETco2 (46 ± 6 versus 52 ± 7 mm Hg; P < 0.001), slower respiratory rate (24 ± 6 versus 30 ± 6 min1; P < 0.001), lower WOB (0.54 ± 0.54 versus 0.95 ± 0.72 JL1; P < 0.05), lower pressure time product (94 ± 88 versus 150 ± 90 cm H2O s1min1; P < 0.001), lower
esophageal pressure (10.6 ± 7.4 versus 14.1 ± 8.9 cm H2O; P < 0.05), lower inspiratory time fraction (29% ± 3% versus 34% ± 5%; P < 0.001), and higher expired tidal volume (179 ± 50 versus 129 ± 44 mL; P < 0.001). There were no differences in Spo2, respiratory drive, mean arterial blood pressure, and heart rate. We conclude that PSV improves gas exchange and reduces WOB during ProSealTM laryngeal mask airway anesthesia compared with CPAP in ASA physical status I children aged 17 yr. | Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Premedication consisted of oral midazolam 0.5 mg/kg and atropine 20 µg/kg 45 min preoperatively. A standard anesthesia protocol was followed and routine monitoring applied. Anesthesia was induced with propofol 4 mg/kg. A single experienced PLMA user (CK, >1000 uses) inserted/fixed the PLMA (size 2 in all patients) according to the manufacturers instructions (10). Additional boluses of propofol 1 mg/kg were given as required until an adequate level of anesthesia was achieved for placement. Anesthesia maintenance consisted of sevoflurane 2% and O2 35% in air. In all children, intraoperative analgesia was performed with a caudal block using ropivacaine 0.2% 11.25 mL/kg. Once an effective airway was obtained, the intracuff pressure was set and held constant at 60 cm H2O using a digital manometer (Mallinckrodt Medical, Athlone, Ireland). Oropharyngeal leak pressure was determined by closing the expiratory valve of the anesthesia breathing system at a fixed gas flow of 3 L/min and noting the airway pressure (maximum allowed, 40 cm H2O) at which equilibrium was reached (11). Epigastric auscultation was performed during oropharyngeal leak pressure testing to detect any gastric insufflation (12). The lungs were manually inflated until SB resumed. Patients were then attached to a ventilator (modified Evita 4; Draeger Medizintechnik GmbH, Luebeck, Germany) and were randomly allocated into two crossover groups. In Group 1 (n = 10), patients underwent CPAP, PSV, and CPAP in sequence. In Group 2 (n = 10), patients underwent PSV, CPAP, and PSV in sequence. PSV comprised positive end-expiratory pressure (PEEP) set at 3 cm H2O and pressure support set at 10 cm H2O above PEEP. CPAP was set at 3 cm H2O. Pressure support was initiated when inspiration produced a 2-cm H2O reduction in airway pressure and a flow of 2.5 L/min. The machine had no bias flow. Each ventilatory mode was maintained for 5 min.
Respiratory variables were measured and analyzed using a pulmonary monitor (CP-100; BiCore Monitoring System, Irvine, CA) attached to a variable orifice pneumotachograph (Var flex; Allied Health Products, Riverside, CA) and an esophageal balloon catheter inserted through the drain tube of the PLMA (Smart Cath; Allied Health Products) (1315) (Fig. 1) (14,15). The esophageal balloon catheter was 3 mm in diameter, 70 cm long, and constructed from medical-grade polyurethane. The inflated balloon was 0.9 cm in diameter and 10 cm long. The frequency response was 30 Hz. The esophageal balloon catheter was connected directly to the catheter port on the BiCore monitoring system. The BiCore monitoring system automatically performs a vacuum leak test and fills the esophageal balloon with 0.8 mL of air. The pneumotachograph was connected directly to the proximal end of the airway tube measuring airway pressure and flow. The CO2 sampling port was sited above the flow transducer. The position of the esophageal balloon catheter was checked and adjusted where necessary by observation of the cardiac artifact on the esophageal waveform, as recommended by the manufacturer. The classical airway occlusion test was not used, because the patients were not yet spontaneously breathing. The machine pop-off valve was set at 40 cm H2O.
|
The following data were recorded every 30 s for the last 2 min of each ventilatory mode and the average reading taken: ETco2, Spo2, noninvasive mean arterial blood pressure, end-tidal sevoflurane concentration, fraction of inspired oxygen, axillary skin temperature, expired tidal volume (VTExp), respiratory rate, peak airway pressure, WOB (sum of the physiologic work, including elastic and flow resistive work of the respiratory system and airway device), pressure time product (PTP),
esophageal pressure, inspiratory time fraction, and respiratory drive. Any ingestion or expulsion of air via the drain tube was detected by observing movement of a column of lubricant placed in the drain tube before and after esophageal balloon catheter insertion. Measurements were made before surgery.
Sample size was selected for a type I error of 0.05 and a power of 0.9 and was based on a pilot study of 6 patients with a measured difference in the VTExp of 25% between the groups. The distribution of data was determined using Kolmogorov-Smirnov analysis (16). Statistical analysis was with paired t-test (normally distributed data) and Friedmans two-way analysis of variance (non-normally distributed data). Within-patient variability of each set was determined using one-way analysis of variance. Significance was taken as P < 0.05.
| Results |
|---|
|
|
|---|
esophageal pressure (P < 0.05), and higher VTExp (P < 0.001) compared with CPAP (Table 2). In both groups, PSV had similar Spo2, respiratory drive, mean arterial blood pressure, and heart rate compared with CPAP. Data for CPAP were similar between groups and for PSV were similar between groups. Gastric insufflation was not detected during oropharyngeal leak pressure testing.
|
|
| Discussion |
|---|
|
|
|---|
WOB is increased in spontaneously breathing patients undergoing general anesthesia with an artificial airway (18). We found that PSV resulted in approximately 40% reduction in WOB compared with CPAP. This is because the ventilator is providing much of the energy required to deliver each breath. The PTP is an estimate of the oxygen consumption or metabolic work of the respiratory muscles and may be used to evaluate patient effort to overcome both mechanical and isometric force of inspiration during mechanical ventilation (19,20). The decrease in PTP from CPAP to PSV reflects the reduced respiratory muscle workload and the increased ventilator workload.
We found that that the oropharyngeal leak pressure was 25 cm H2O. This is 13 cm H2O higher than with the classic LMA using the same methodology in children of similar age (21). This suggests that the size 2 PLMA forms a better seal that the classic LMA, but a comparative study between the 2 devices is required to confirm this. We detected no episodes of gastric insufflation during oropharyngeal leak pressure testing. PSV and CPAP should be safer with the PLMA than the classic LMA, because the efficacy of the seal with the hypopharynx is probably greater (22) and any esophageal leaks should be vented from the drain tube if it is correctly positioned. We detected no differences in cardiovascular effects between PSV and CPAP. This is not surprising, because intrathoracic pressure changes were only 7 cm H2O higher for PSV.
Our study has a number of limitations. First, only healthy ASA physical status I children without underlying respiratory disease or obesity were enrolled in the study and our results may not be applicable to other patient populations. Second, we did not measure the arterial partial pressure of oxygen, which is a more sensitive test of oxygenation than oxygen saturation, and it is possible that subtle differences in oxygenation went undetected. Third, the data were collected over a short period before commencement of surgery and, in principle, our results may not be applicable to prolonged SB. However, if anything, the differences between PSV and CPAP are likely to increase with duration because of greater respiratory fatigue with CPAP.
We conclude that PSV improves gas exchange and reduces WOB during PLMA anesthesia compared with CPAP in ASA physical status I children aged 17 years.
| Footnotes |
|---|
This project was supported solely by departmental resources.
JB and CK have worked as consultants for The Laryngeal Mask Company, who manufacture the ProSealTM laryngeal mask airway.
Accepted for publication August 11, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Garcia-Fernandez, G. Tusman, F. Suarez-Sipmann, J. Llorens, M. Soro, and J. F. Belda Programming Pressure Support Ventilation in Pediatric Patients in Ambulatory Surgery with a Laryngeal Mask Airway Anesth. Analg., December 1, 2007; 105(6): 1585 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Goldmann, C. Roettger, and H. Wulf Use of the ProSealTM laryngeal mask airway for pressure-controlled ventilation with and without positive end-expiratory pressure in paediatric patients: a randomized, controlled study Br. J. Anaesth., December 1, 2005; 95(6): 831 - 834. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|